2013
DOI: 10.1086/674768
|View full text |Cite
|
Sign up to set email alerts
|

Coagulation and the Vessel Wall in Pulmonary Embolism

Abstract: Venous thromboembolism comprises deep-vein thrombosis, thrombus in transit, acute pulmonary embolism, and chronic thromboembolic pulmonary hypertension (CTEPH). Pulmonary thromboemboli commonly resolve, with restoration of normal pulmonary hemodynamics. When they fail to resorb, permanent occlusion of the deep veins and/or CTEPH are the consequences. Apart from endogenous fibrinolysis, venous thrombi resolve by a process of mechanical fragmentation, through organization of the thromboembolus by invasion of end… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
20
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(24 citation statements)
references
References 130 publications
1
20
0
1
Order By: Relevance
“…It did not result in hemodynamically relevant pulmonary embolisms leading to PAH and only caused very mild pulmonary arterial endothelial dysfunction. This corroborates the existing evidence in literature, which has repeatedly reported on the hardships to induce PE in mice and other animals [ 20 ]. This phenomenon has best been described in dogs, which are resistant to sustained DVT or PE because of high endogenous thrombolytic activity [ 21 ], probably caused by increased plasmin and/or plasminogen activity [ 22 ].…”
Section: Discussionsupporting
confidence: 92%
“…It did not result in hemodynamically relevant pulmonary embolisms leading to PAH and only caused very mild pulmonary arterial endothelial dysfunction. This corroborates the existing evidence in literature, which has repeatedly reported on the hardships to induce PE in mice and other animals [ 20 ]. This phenomenon has best been described in dogs, which are resistant to sustained DVT or PE because of high endogenous thrombolytic activity [ 21 ], probably caused by increased plasmin and/or plasminogen activity [ 22 ].…”
Section: Discussionsupporting
confidence: 92%
“…Chronic thromboembolic pulmonary hypertension (CTEPH) is a disease defined by the presence of chronic clot accompanied by vascular remodeling and pulmonary arterial hypertension. [1][2][3][4][5] Despite the introduction of pharmacologic therapies for CTEPH, 6 pulmonary thromboendarterectomy (PTE) remains the gold-standard treatment for advanced, symptomatic disease. 1 While imaging is important for both the diagnosis of CTEPH and evaluation for PTE, 7,8 interpretation of vascular morphology remains challenging.…”
mentioning
confidence: 99%
“…In both PTE animal models and PTE patients, alternations of pulmonary endothelium function have been observed, such as procoagulant activity and fibrinolytic function, along with a noticeable increase in the blood concentration of plasminogen activator inhibitor type I and arginase II protein in PTE patients[51,54]. On one hand, PTE might lead to the dysfunction of endothelial cells through both mechanical and inflammatory insults, with both the lysing thrombus and mechanical effects of thrombotic occlusion damaging the endothelium of the vein[55]; while on the other hand, considering the necessity ofendothelial cells in the resolution of venous thrombi, dysfunctional endothelial cells may contribute to the further progression of the PTE diseases[56,57]. Our data confirmed previous hypothesis that PTE induced dramatic gene expression alterations in pulmonary artery.…”
Section: Discussionmentioning
confidence: 99%